Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
whole-blood level | concentration measured in whole blood | The tacrolimus whole-blood level is listed with the assay method. | Objective | Drug levels - analyte, specimen and reporting |
free concentration | amount of drug measured in the unbound fraction | The phenytoin free concentration is reported separately from total drug. | Objective | Drug levels - analyte, specimen and reporting |
total concentration | bound and unbound drug measured together | The total concentration was measured on the same draw as free drug. | Objective | Drug levels - analyte, specimen and reporting |
unbound fraction | proportion of the total drug that is not protein bound | The report gives the unbound fraction as a percentage. | Objective | Drug levels - analyte, specimen and reporting |
protein-bound fraction | portion of drug attached to circulating proteins | The specialist report distinguishes the protein-bound fraction from the unbound portion. | Objective | Drug levels - analyte, specimen and reporting |
| original compound measured separately from its metabolites | The parent drug and active metabolite appear on separate report lines. | Objective | Drug levels - analyte, specimen and reporting | |
active metabolite | metabolic product that has pharmacologic activity | The laboratory measured the active metabolite separately. | Objective | Drug levels - analyte, specimen and reporting |
analyte | substance the assay measures | The analyte on the outside report is total phenytoin. | Objective | Drug levels - analyte, specimen and reporting |
assay method | technique used to obtain a reported concentration | The assay method is specified on the transplant laboratory report. | Objective | Drug levels - analyte, specimen and reporting |
| test that uses antibody recognition | The outside concentration was measured by immunoassay. | Objective | Drug levels - analyte, specimen and reporting | |
mass spectrometry | method identifying or measuring analytes by mass-to-charge ratio | The laboratory measured the drug using liquid chromatography with tandem mass spectrometry. | Objective | Drug levels - analyte, specimen and reporting |
chromatography | separation technique used before detection in some assays | The assay used liquid chromatography before detection. | Objective | Drug levels - analyte, specimen and reporting |
| material of known value used to establish assay response | The laboratory repeated analysis after checking the calibrator. | Objective | Drug levels - analyte, specimen and reporting | |
calibration curve | relationship between instrument response and known concentration | The laboratory report references the validated calibration curve. | Objective | Drug levels - analyte, specimen and reporting |
reportable range | interval over which the laboratory reports a validated measurement | The result exceeds the upper end of the assay's reportable range. | Objective | Drug levels - analyte, specimen and reporting |
quantitation limit | boundary for reliable numerical measurement | The laboratory reported the value as below its lower quantitation limit. | Objective | Drug levels - analyte, specimen and reporting |
detection limit | lowest amount distinguishable from background under stated conditions | The report lists the assay's detection limit alongside the qualitative result. | Objective | Drug levels - analyte, specimen and reporting |
below quantification | present or reported below a reliable numeric reporting limit | The analyte was reported as below quantification without an exact concentration. | Objective | Drug levels - analyte, specimen and reporting |
upper limit | highest applicable value on a stated scale or interval | The assay upper limit is given in the laboratory comment. | Objective | Drug levels - analyte, specimen and reporting |
lower limit | lowest applicable value on a stated scale or interval | The numeric result includes a qualifier at the reporting lower limit. | Objective | Drug levels - analyte, specimen and reporting |
dilution factor | number used to account for dilution in measurement | The reference laboratory documented the applied dilution factor. | Objective | Drug levels - analyte, specimen and reporting |
specimen matrix | type of material tested, such as serum or whole blood | The original report identifies the specimen matrix as plasma. | Objective | Drug levels - analyte, specimen and reporting |
aliquot volume | amount of specimen separated for analysis | The laboratory documented insufficient aliquot volume for the free level. | Objective | Drug levels - analyte, specimen and reporting |
sample integrity | condition of the specimen on receipt | The laboratory noted a sample integrity concern on arrival. | Objective | Drug levels - analyte, specimen and reporting |
assay interference | another substance or condition alters the measurement | The laboratory appended a comment about possible assay interference. | Objective | Drug levels - analyte, specimen and reporting |